SM was also demonstrated to have inhibitory effects on obesity-induced growth and ROS production associated with decreased production of proinflammatory IL-6 and IL-1β in HepG2 cells exposed to sera from obese individuals [62]. The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.